# Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients

> **NCT00161369** · — · COMPLETED · sponsor: **University of Shizuoka** · enrollment: 200 (—)

## Conditions studied

- Chronic Renal Failure
- Hemodialysis
- Atherosclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00161369
- **Lead sponsor:** University of Shizuoka
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 200 (—)
- **Last updated:** 2005-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161369, "Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00161369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*